Ariad Pharmaceuticals Inc fka ARIA

[vidpok45]

Despite an increase in short shares, we now see resistance by longs to the classic short walk downs. Why is this the case? Longs now are empowered as they see progress on all fronts and expect an approval for ponatinib in Asia at any time. This major catalyst and the forthcoming 113 approval will greatly improve revenue in the years to come with year after year increases in earnings which will drive the sp higher. If the process isnt interrupted by a buyout then the share price could reach former highs in a relatively short time. I feek confident Denner wont entertain lowball offers under 20 now and expect he wouldnt consider an offer under 25 after all the great news recently. Those here who posited a decreased short position were completely wrong. The sp is rising based on renewed optimism and expectations of more good news on the products. I do think the shorts are boxed in and have to start to cover soon which will just exacerbate the sp surge...should be terrific for the longs.